2,4,6-Trichloroaniline, 95.0%, 25g

1-Benzhydryl-3,3-difluoroazetidine, 95.0%, 10g

1,3-dimethyl-2,6-diphenylpiperidin-4-one, 95.0%, 1g

2-Amino-4-nitrobenzonitrile, 95.0%, 1g

1-Bromo-3-chloropropane, min.99%, pour la synthèse, 250 ml, emballage en verre

(S)-5-(8,9,10,11,12,13,14,15-Octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-5H-dibenzo[b,f]azepine, 98%, 5g

1-Butyl-3-phenylthiourea, 100mg

2,5-Dioxopyrrolidin-1-yl 3-(3-methyl-3H-diazirin-3-yl)propanoate, 97%, 1g

2-AMINO-5,6,7,8-TETRAHYDROQUINAZOLIN, 97.0%, 5g

2-Amino-3-methyl-3-phenylbutanoic acid hydrochloride, 98%, 100mg

1,1,4,7,10,10-Hexamethyltriethylenetetramine>98.0%(T)25mL

(4-Acetyl-2-fluorophenyl)boronic acid, 95%, 1g

2-[(4S,5R)-4,5-Dihydro-4,5-diphenyl-2-oxazolyl]phenol, 250mg